NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.23% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.12% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 5.09% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.05% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.87% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.78% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.77% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.56% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.03% |
| VCEL | Vericel Corp Ord | Healthcare | Biotechnology | 3.02% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.02% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.89% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 2.88% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.88% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.87% |